3DMEDiTECH, a partner of ARC CMIT has designed and produced a 3D printed nasopharygeal swab for coronavirus (COVID-19) testing that has been approved by the Therapeutic Goods Administration.
The Australian Government has signed a $3.7 million contract with 3DMEDiTECH to supply sterile nasal swab kits to the National Medical Stockpile.
3DMeditech will supply Australian made, 3D printed nasopharyngeal swab kits. The kits will be issued from the stockpile to general practitioners, private pathology providers and state and territory governments according to their need for on going coronavirus testing.
The kits will include a nasopharyngeal swab, viral transport “media” (salt solution), and a bio hazard bag.
Congratulations to 3DMEDiTECH!
For more details visit:
#COVID19 #medtech #diagnostic #biomedicalengineering #medtech